The World Health Organization conducted a workshop to improve genomic surveillance, data sharing, and bioinformatics analysis for respiratory viruses in order to fortify national, regional, and international genomic surveillance capacities and capabilities within the Global Influenza Surveillance and Response System (GISRS).
Almaden Genomics launched a new Data Management and Informatics Services business to support its bioinformatics and computational biology solutions. The service business was launched to address the critical challenges faced by researchers, pharmaceutical companies, and biotech organizations.
Inocras Inc., announced that it offers whole genome sequencing services using the UG 100 sequencer from Ultima Genomics, Inc.
Bioinformatics is a field that uses computational technology to analyze and interpret biological data, playing a key role in gene expression, protein regulation, and evolutionary biology. It aids in structural biology by simulating DNA, RNA, proteins, and biomolecular interactions.
One major achievement is the analysis of the human genome. With the rise of drug discovery and the need for novel drug targets, bioinformatics is in high demand. Advancements in DNA sequencing and government support for omics research (genomics, proteomics, metabolomics, and transcriptomics) further drive market growth.
The bioinformatics market was estimated at US$ 11.53 billion in 2023 and is projected to grow to US$ 47.48 billion by 2034, rising at a compound annual growth rate (CAGR) of 13.73% from 2024 to 2034. The increasing genomic and proteomic research, novel drug discovery & development, and technological advancements drive the market.
Source: https://lnkd.in/dzJ_BkBw
Access to the exclusive statistics now: https://lnkd.in/deNUJyGg
#Bioinformatics #Genomics #Proteomics #DrugDiscover #HumanGenome
#ComputationalBiology #MolecularBiology #Omics #BioTech #BioinformaticsResearch #DNASequencing #StructuralBiology #ProteinModeling #GenomeAnalysis #HealthTech
